Clinical Trial

Prevalence of NAFLD in T1DM Patients

Study acronym: PAD1ZOL
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 28, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
To determine the prevalence of NAFLD in T1DM patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-03.
Trial Details
NCT Number NCT06445361
Lead Sponsor Ziekenhuis Oost-Limburg
Conditions NAFLD, Type 1 Diabetes, Fatty Liver, Nonalcoholic
Enrollment 138 participants
Start Date 2023-07-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-28